Samples Available Now: Vaccinia Capping System mRNA Guanylyltransferase and mRNA Methyltransferase
mRNA Vaccinia Capping System: Proven. Scalable.
Tailored to the needs of biopharma companies developing mRNA-based therapies
A decade of capping enzyme experience, coming soon to you (Q4 2025*):
Roche’s vaccinia capping enzymes
- mRNA Guanylyltransferase, rec., GMP Grade, AOF and
- mRNA Methyltransferase, rec., GMP Grade, AOF
Quality by design
Fit-for-purpose & GMP Grade to ensure compliance and minimize your overall risks
Scalable solution
Suitable for various scales of mRNA production from R&D to commercial manufacturing
Robust supply
Enhance business continuity and benefit from greater financial control
Proven expertise
A decade of manufacturing capping enzymes - before, during and beyond the COVID-19 pandemic
Ready to discover CustomBiotech's Vaccinia Capping System?
Request your free pre-launch test sample here
Source from a strong partner for robust supply
Roche CustomBiotech is ready to support your mRNA project
Discover more
*Availability subject to change.
Regulatory disclaimer:
Pre-launch sample: Intended for evaluation purposes. Final product: For further processing into medical devices, IVD and pharmaceutical products only.
Please see product pages for warranty limitations and legal notes.
